PUBLISHER: IMARC | PRODUCT CODE: 1800962
PUBLISHER: IMARC | PRODUCT CODE: 1800962
The global positive airway pressure devices market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.14% during 2025-2033. The increasing occurrence of depression, hypertension, diabetes, and heart disorders is stimulating the market.
Increasing Prevalence of Sleep Apnea
The rising awareness towards the occurrence of sleep disorders is escalating the demand for diagnosis and treatment, which is catalyzing the market. For example, in May 2024, Dutch healthcare company Philips launched continuous positive airway pressure (CPAP) therapy devices that are used to treat sleep apnea. Moreover, in India, Philips offered support through a hotline and website. This is contributing to the positive airway pressure devices market outlook.
Rising Technological Advancements
Continuous innovations, which enhance treatment efficacy, automatically adjust pressure levels based on the user's needs, elevate patient comfort, etc., are stimulating the market. Furthermore, advances in mask design with features aimed at minimizing noise are also propelling the overall market. In July 2024, Varon, previously known for oxygen concentrator solutions, introduced its new Sunnygrand series that offer effective and comfortable treatment for sleep apnea patients, integrating with doctors' prescribed settings and therapy plans. It also supports ongoing monitoring and adjustments by healthcare professionals. As per the positive airway pressure devices market analysis report, it is acting as a significant growth-inducing factor.
Escalating Demand for Home Healthcare
With the inflating healthcare costs and the increasing emphasis on patient-centric care, more individuals are opting for home-based management of sleep apnea. It allows healthcare providers to monitor and adjust treatment remotely. In March 2024, React Health developed a travel CPAP called the Luna TravelPAP. It is a small, lightweight positive airway pressure device with CPAP and AutoCPAP modes. Additionally, it has supply reminders, an optional carrying case, a light ring indicator, etc.
Continuous positive airway pressure (CPAP) devices dominate the total positive airway pressure devices market share
The inflating requirement for enhanced user comfort and treatment efficacy is driving the segment's growth. For example, the development of ResMed's AirSense 11, which features an auto-adjusting algorithm and integrated connectivity that enables personalized therapy adjustments and remote monitoring.
Hospitals and sleep labs hold the majority of the global positive airway pressure devices market demand
In these clinical settings, advanced PAP devices are utilized to ensure accurate diagnosis and effective treatment. For example, the Philips Respironics DreamStation BiPAP AutoSV is frequently adopted in hospitals for patients with complex sleep apnea, owing to its ability to adjust pressure levels automatically based on the patient's needs. This is expanding the positive airway pressure devices market forecast report.
North America exhibits a clear dominance in the market
The positive airway pressure devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The widespread prevalence of sleep apnea and other respiratory disorders is augmenting the positive airway pressure devices market outlook report in North America. In February 2024, ResMed introduced its AirCurve 11 series bilevel positive airway pressure devices in the U.S. It is designed to help providers treat sleep apnea while patients start and stay on therapy.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: